Skip to main content
The Egyptian Journal of Internal Medicine
Download PDF
  • Original article
  • Open access
  • Published:

Is serum apelin related to portal hemodynamics in patients with liver cirrhosis?

The Egyptian Journal of Internal Medicine volume 30, pages 8–12 (2018)Cite this article

Abstract

Background

Apelin is the endogenous ligand of the angiotensin-like receptor. The expression of apelin–APJ (apelin receptor) signaling is associated with the development of portal hypertension (PH) and contributes toward the formation of Porto systemic collaterals and splanchnic neovascularization in PH.

Aims

We aimed to study the relationship between apelin and portal hemodynamics in cirrhotic patients.

Patients and methods

Thus study included 60 cirrhotic patients from Menoufia University Hospitals (Egypt) and 20 healthy volunteers as a control group. Participants underwent a physical examination and laboratory investigations [complete blood count, urea, creatinine, alanine transaminase, aspartate transaminase (AST), serum albumin, bilirubin, international normalized ratio, hepatitis C virus antibody, hepatitis B virus antigen, hepatitis C virus PCR, alpha feto protein (AFP), and serum level of apelin]. Abdominal ultrasonographic studies of portal vein diameter, splenic size, and portal hemodynamics were carried out for all participants. Child–Pugh score, model for end-stage liver disease score, and AST/platelet (PLT) index were calculated for all participants.

Results

Serum apelin was highly significantly elevated in cirrhotics than in controls, with a P value of 0.001. Serum apelin was significantly correlated to some laboratory parameters in cirrhotics such as PLT count, alanine transaminase, AST, γ-glutamyl transferase, and bilirubin, with P value less than 0.05. There was a positive correlation between serum apelin level and the degree of liver fibrosis estimated by the AST/PLT index. Serum apelin was significantly correlated to portal vein diameter and portal flow velocity, with a P value less than 0.05, and highly significantly correlated to splenomegaly, with a P value of 0.001. The optimal cut-off point of serum apelin for the prediction of PH in cirrhotics is 2550 ng/dl, with a sensitivity of 89%, a specificity of 65%, and an accuracy of 81%.

Conclusion

Serum apelin is elevated in patients with cirrhosis and PH, and a positive correlation is found between serum apelin and the degree of hepatic fibrosis. Measurement of serum apelin represents a rapid, noninvasive method for the prediction of PH in cirrhotics and can assess the degree of hepatic fibrosis.

References

  1. Gatta A, Bolognesi M, Merkel C. Vasoactive factors and hemodynamic mechanisms in the pathophysiology of portal hypertension in cirrhosis. Mol Aspects Med 2008; 29:119–129.

    Article  CAS  Google Scholar 

  2. Altinkaya SÖ, Nergiz S, Küçük M, Yüksel H. Apelin levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 2014; 176:168–172.

    Article  CAS  Google Scholar 

  3. Kasai A, Shintani N, Kato H, Matsuda S, Gomi F, Haba R, et al. Retardation of retinal vascular development in apelin-deficient mice. Arterioscler Thromb Vasc Biol 2008; 28:1717–1722.

    Article  CAS  Google Scholar 

  4. Cox CM, D’Agostino SL, Miller MK, Heimark RL, Krieg PA. Apelin, the ligand for the endothelial G-protein-coupled receptor, APJ, is a potent angiogenic factor required for normal vascular development of the frog embryo. Dev Biol 2006; 296:177–189.

    Article  CAS  Google Scholar 

  5. Tiani C, Garcia-Pras E, Mejias M, de Gottardi A, Berzigotti A, Bosch J, et al. Apelin signaling modulates splanchnic angiogenesis and portosystemic collateral vessel formation in rats with portal hypertension. J Hepatol 2009; 50:296–305.

    Article  CAS  Google Scholar 

  6. Masri B, Knibiehler B, Audigier Y. Apelin signalling: a promising pathway from cloning to pharmacology. Cell Signal 2005; 17: 415–426.

    Article  CAS  Google Scholar 

  7. Devic E, Rizzoti K, Bodin S, Knibiehler B, Audigier Y. Amino acid sequence and embryonic expression of MSR/APJ, the mouse homolog of Xenopus X-msr and human APJ. Mech Dev 1999; 84:199–203.

    Article  CAS  Google Scholar 

  8. Inui M, Fukui A, Ito Y, Asashima M. Xapelin and Xmsr are required for cardiovascular development in Xenopus laevis. Dev Biol 2006; 298: 188–200.

    Article  CAS  Google Scholar 

  9. Saint-Geniez M, Masri B, Malecaze F, Knibiehler B, Audigier Y. Expression of the murine MSR/APJ receptor and its ligand apelin is upregulated during formation of the retinal vessels. Mech Dev 2002; 110:183–186.

    Article  CAS  Google Scholar 

  10. Saint-Geniez M, Argence CB, Knibiehler B, Audigier Y. The MSR/APJ gene encoding the apelin receptor is an early and specific marker of the venous phenotype in the retinal vasculature. Gene Expr Patterns 2003; 3:467–472.

    Article  CAS  Google Scholar 

  11. Kasai A, Shintani N, Oda M, Kakuda M, Hashimoto H, Matsuda T, et al. Apelin is a novel angiogenic factor in retinal endothelial cells. Biochem Biophys Res Commun 2004; 325:395–400.

    Article  CAS  Google Scholar 

  12. Masri B, Morin N, Cornu M, Knibiehler B, Audigier Y. Apelin (65–77) activates p70 S6 kinase and is mitogenic for umbilicalendothelial cells. FASEB J 2004; 18:1909–1911.

    Article  CAS  Google Scholar 

  13. Kidoya H, Ueno M, Yamada Y, Mochizuki N, Nakata M, Yano T, et al. Spatial and temporal role of the apelin/APJ system in the caliber size regulation of blood vessels during angiogenesis. EMBO J 2008; 27: 522–534.

    Article  CAS  Google Scholar 

  14. Sorli SC, Le Gonidec S, Knibiehler B, Audigier Y. Apelin is a potent activator of tumour neoangiogenesis. Oncogene 2007; 26: 7692–7699.

    Article  CAS  Google Scholar 

  15. Principe A, Melgar-Lesmes P, Fernandez-Varo G, Ruiz del Arbol L, Ros J, Morales-Ruiz M, et al. The hepatic apelin system: a new therapeutic target for liver disease. Hepatology 2008; 48:1193–1201.

    Article  CAS  Google Scholar 

  16. Sorli SC, van den Berghe L, Masri B, Knibiehler B, Audigier Y. Therapeutic potential of interfering with apelin signalling. Drug Discov Today 2006; 11:1100–1106.

    Article  CAS  Google Scholar 

  17. Melgar-Lesmes P, Casals G, Pauta M, Ros J, Reichenbach V, Batallar R, et al. Apelin mediates the induction of profibrogenic genes in human hepatic stellate cells. Endocrinology 2010; 151: 5306–5314.

    Article  CAS  Google Scholar 

  18. Yokomori H, Oda M, Yoshimura K, Machida S, Kaneko F, Hibi T. Overexpression of apelin receptor (APJ/AGTRL1) on hepatic stellate cells and sinusoidal angiogenesis in human cirrhotic liver. J Gastroenterol 2011; 46:222–231.

    Article  CAS  Google Scholar 

  19. Bertolani C, Marra F. The role of adipokines in liver fibrosis. Pathophysiology 2008; 15:91–101.

    Article  CAS  Google Scholar 

  20. Lim YL, Choi E, Jang YO, Cho YZ, Kang YS, Baik SK, et al. Clinical implications of the serum apelin level on portal hypertension and prognosis of liver cirrhosis. Gut Liver 2016; 10:109–116.

    Article  CAS  Google Scholar 

  21. Garica-Diaz D, Campion J, Milagro FI, Martinez JA. Adiposity dependent apelin gene expression: relationships with oxidative and inflammation markers. Mol Cell Biochem 2007; 305:87–94.

    Article  Google Scholar 

  22. Bataller R, Sancho-Bru P, Ginès P, Lora JM, Al-Garawi A, Sole M, et al. Activated human hepatic stellate cells express the renin-angiotensin system and synthesize angiotensin II. Gastroenterology 2003; 125: 117–125.

    Article  CAS  Google Scholar 

  23. Lindahl P, Johansson BR, Levéen P, Betsholtz C. Pericyte loss and microaneurysm formation in PDGF-B deficient mice. Science 1997; 277: 242–245.

    Article  CAS  Google Scholar 

  24. El-Mesallamy HO, Hamdy NM, Rizk HH, El-Zayadi AR. Apelin serum level in Egyptian patients with chronic hepatitis C. Mediators Inflamm 2011; 703031:7.

    Google Scholar 

  25. Sagiroglu T, Aksoy MB, Sagiroglu G, Tozkir H, Oguz S, Yalta T, et al. Effect of leptin and apelin preconditioning on hepatic ischemia reperfusion injury in rats. Indian J Surg 2014; 76:111–116. ?

    Article  Google Scholar 

  26. Farid RM, Abu-Zeid RM, El-Tawil A. Emerging role of adipokine apelin in hepatic remodelling and initiation of carcinogensis in chronic hepatitis C patients. Int J Clin Exp Pathol 2014; 7: 2707–2717.

    PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Faculty of Medicine, Menoufia University, Menoufia, Egypt

    Ashraf G. Dala MD

  2. Department of Diagnostic Radiology, Faculty of Medicine, Menoufia University, Menoufia, Egypt

    Osama M. Ebied

  3. Department of Department of Clinical Pathology, National Liver Institute, Menoufia University, Menoufia, Egypt

    Gamal Y. Abo-Raia

Authors
  1. Ashraf G. Dala MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Osama M. Ebied
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gamal Y. Abo-Raia
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ashraf G. Dala MD.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dala, A.G., Ebied, O.M. & Abo-Raia, G.Y. Is serum apelin related to portal hemodynamics in patients with liver cirrhosis?. Egypt J Intern Med 30, 8–12 (2018). https://doi.org/10.4103/ejim.ejim_61_17

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.4103/ejim.ejim_61_17

Keywords